IP Library › Assignment 059043/0226

Patent Assignment

Reel/Frame 059043/0226

Release of Security Interest

Recorded: 2022-02-18 Pages: 9

View PDF Order Certified Copy

Assignor

CAPITAL ONE, NATIONAL ASSOCIATION

Executed: 2022-01-04

Assignee

COVIS PHARMA GMBH

GRAFENAUWEG 12, ZUG, 6300, SWITZERLAND

Covered Properties (37)

Aqueous Suspensions of Ciclesonide for Nebulisation

Patent: 11,052,042 →

Application: 14/865,637 →

Publication: US US20160015634A1

Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation

Patent: 11,007,150 →

Application: 14/238,055 →

Publication: US US20140170081A1

Use of Ciclesonide for the Treatment of Respiratory Diseases

Application: 16/440,557 →

Publication: US US20190290661A1

Methods of Reducing Risk of Preterm Birth

Patent: 11,154,562 →

Application: 16/580,669 →

Publication: US US20200188413A1

Anticoagulant Reversal Agents

Application: 15/726,497 →

Publication: US US20180207152A1

Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa

Patent: 6,767,901 →

Application: 10/110,629 →

Ciclesonide Containing Aqueous Pharmaceutical Composition

Patent: 8,383,611 →

Application: 10/110,632 →

Ciclesonide containing sterile aqueous suspension

Patent: 8,481,516 →

Application: 12/448,351 →

Publication: US US20100009951A1

Ciclesonide-Containing Sterile Aqueous Suspension

Patent: 8,268,240 →

Application: 12/461,647 →

Publication: US US20100034696A1

Ciclesonide-Containing Sterile Aqueous Suspension

Patent: 8,182,824 →

Application: 10/519,484 →

Publication: US US20060166953A1

Combination Medicament

Patent: 8,258,124 →

Application: 12/973,350 →

Publication: US US20110086827A1

Combination Medicament

Patent: 7,879,833 →

Application: 10/537,356 →

Publication: US US20060025392A1

Combination of riluzole and of gabapentin and its use as a medicament

Patent: 6,350,768 →

Application: 09/718,543 →

Compliance monitor and method

Patent: 8,464,707 →

Application: 10/572,316 →

Publication: US US20070023034A1

Formoterol and Ciclesonide Combination

Patent: 8,435,497 →

Application: 10/559,383 →

Publication: US US20060127323A1

Metered Dose Inhaler

Patent: 582,544 →

Application: 29/283,277 →

Process for preparing crystalline ciclesonide with defined particle size

Patent: 9,422,327 →

Application: 10/549,631 →

Publication: US US20060128954A1

Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation

Patent: 7,468,433 →

Application: 10/399,689 →

Publication: US US20050080063A1

Riluzole and Alpha-Tocopherol Combination

Patent: 6,642,262 →

Application: 09/854,318 →

Publication: US US20020019426A1

Stabilized Pharmaceutical Product

Patent: 8,440,210 →

Application: 13/437,569 →

Publication: US US20120247982A1

Stabilized Pharmaceutical Product

Patent: 8,163,299 →

Application: 13/219,046 →

Publication: US US20110308975A1

Stabilized Pharmaceutical Product

Patent: 8,029,811 →

Application: 12/771,557 →

Publication: US US20100247585A1

Stabilized Pharmaceutical Product

Patent: 7,736,673 →

Application: 11/259,495 →

Publication: US US20060147537A1

Stable Pharmaceutical Products

Patent: 8,288,445 →

Application: 12/951,608 →

Publication: US US20110064814A1

Stable Pharmaceutical Products

Patent: 7,947,744 →

Application: 11/325,875 →

Publication: US US20060104917A1

Use of Ciclesonide for the Treatment of Respiratory Diseases

Patent: 8,371,292 →

Application: 10/571,311 →

Publication: US US20070025923A1

Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis

Patent: 8,486,923 →

Application: 12/973,414 →

Publication: US US20110092471A1

Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis

Patent: 7,879,832 →

Application: 10/524,821 →

Publication: US US20050245493A1

Heat Stable Colloidal Iron Oxides Coated with Reduced Carbohydrates and Carbohydrate Derivatives

Patent: 6,599,498 →

Application: 09/521,264 →

Methods of Reducing Risk of Preterm Birth

Patent: 9,844,558 →

Application: 15/373,262 →

Methods of Reducing Risk of Preterm Birth

Patent: 10,471,075 →

Application: 15/709,941 →

Crystalline and Amorphous Forms of 17-Alpha-Hydroxyprogesterone Caproate

Patent: 10,556,922 →

Application: 15/764,100 →

Publication: US US20180282366A1

Composition with Sustained Release of Levodopa and Carbidopa

Patent: 6,531,153 →

Application: 09/866,857 →

Publication: US US20020192290A1

Stable Glucagon Formulations

Patent: 9,956,287 →

Application: 14/766,347 →

Publication: US US20150374825A1

Labeled Compounds and Methods of Imaging, Diagnosing Cartilage Disorders and Diseases, and Monitoring Cartilage Health Using Labeled and Unlabeled Compounds

Patent: 9,999,690 →

Application: 14/534,474 →

Publication: US US20150133769A1

Anticoagulant Reversal Agents

Patent: 9,522,892 →

Application: 13/688,442 →

Publication: US US20130137702A1

Anticoagulant Reversal Agents

Patent: 9,877,961 →

Application: 15/348,348 →

Publication: US US20170056396A1

Related Assignments (25)